The Pink Vaccine
The Pink Vaccine
During the summer of 2010, Dr. Vincent Tuohy of the Cleveland Clinic and his team of researchers published their findings about the first preventive breast cancer vaccine in the prestigious journal Nature Medicine. The Pink Vaccine was found to be 100 percent effective in preventing breast cancer in mice that were bred to develop the disease. In the control group, all of the mice developed breast cancer while those who received the vaccination did not.
Tuohy’s team used the protein alpha-lactalbumin as the primary target for his vaccine and found that it both prevented breast cancer and stopped the growth of already existing tumors in animal models. Alpha-lactalbumin is found in the majority of women who are diagnosed with breast cancer, but not in healthy women other than those who are nursing. The plan would be to vaccinate women who are past child-bearing age.
We believe that this vaccine will someday be used to prevent breast cancer in adult women in the same way that vaccines prevent polio and measles in children. If it works in humans the way it works in mice, this will be monumental. We could eliminate breast cancer.Dr. Vincent Tuohy
The Next Steps
The next step to with this research is to start clinical trials and determine whether the Pink Vaccine is as safe and effective in women as it is in mice. The only problem that’s been standing in the way of Dr. Vincent Tuohy’s research is the lack of funding. Major breast cancer organizations have turned down his request for funds. The Susan G. Komen Foundation, for instance, has turned down Tuohy’s request three separate times! Avon as well as the Department of Defense also refuse to fund further research on Tuohy’s vaccine. However, despite these setbacks, a strong and growing grassroots effort by women around the globe has been developing to fund the preventive breast cancer vaccine. The Breast Health and Healing Foundation supports the research behind the Pink Vaccine. All of the donations that our Foundation receives will be going directly to funding the research behind the preventive breast cancer vaccine and the human mammary tumor virus.
Recent Vaccine News
If you’ve been diagnosed with advanced breast cancer, you may be terrified for your life. However, a new study may show a silver lining. The National Cancer Institute reported that the number of women living with advanced breast cancer has grown in the US with...read more
What does space technology and NASA have to do with breast cancer research? More than you’d think! According to the Scientific American magazine, scientists at NASA’s Jet Propulsion Laboratory have moved beyond creating robotic spacecraft and begun using their...read more
As previously reported, Dr. James F. Holland has spent much of his life attempting to uncover the viral causes of breast cancer as well as the potential link between the mouse mammary tumor virus (MMTV) and human breast cancer. Dr. Holland is not the only one that has...read more
A remarkable new treatment for breast cancer has helped save the life of the 69-year-old patient Susan Young, according to City of Hope. The treatment involves a p53 breast cancer vaccine and a medication that stops a cancer-causing protein in its tracks. Young...read more
Innovative research shows that a new type of breast cancer vaccine could effectively treat HER2-positive breast cancer in its early stages, according to the publication Breast Cancer News. The vaccine uses a patient’s dendritic cells to target the HER2 protein and...read more
Good question! Thanks for asking it, Stephie Zimmerman of the Anti-cancer Club. Stephie is an oncology nurse and a childhood cancer survivor, and a razor-sharp interviewer. She asked me this question yesterday when we were discussing the preventive breast cancer...read more